Double blind randomised study into the efficacy of Codeine Phosphate analgesia after cleft palate repair in infants
DEC-NET Serial number GB277
Published online07/07/2004 13.13.00
Last updated02/08/2005 14.00.32
Other protocol ID numberN0012128260
This trial has been approved by an ethics committee
Current trial statusOpen (actively recruiting new participants)
Major Disease
(ICD9 class)
CLEFT PALATE NOS
Experimental drug
Codeine Phosphate
GenderBoth
Age (range)0 -2 years

Eligibility criteria
Inclusion criteria
Infants with cleft palates undergoing surgical repair
Exclusion criteria
Informed consent not given

Trial design/methodology
Phase4
Kind of studyEfficacy
Pharmacokinetics
DesignControlled
Randomised
Blinded
Double blind
Purpose of study
To determine the efficacy of Codeine Phosphate after cleft palate repair in infants, and to determine how much is metabolised to morphine in this age group
Primary outcomes
Reduction in pos-operative pain
Secondary outcomes
Metabolism to Morphine
Summary of study design, objectives, and ongoing research findings
Double blind randomised study. Random allocation (A) Codeine phosphate after cleft palate repair (B) No codeine phosphate .
Principal investigator
NameDr MRJ Sury
InstitutionGreat Ormond Street Hospital
Postal addressAnaesthetics, Great Ormond Street Hospital, Great Ormond Street, London, WC1N 3JH
CityLondon
CountryUNITED KINGDOM
Phone020 7405 9200 Ext 5399
Fax
E-mail

ISRCTN  EudraCT